Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 30% ± 12% | |
| endothelial cell | 8 studies | 24% ± 6% | |
| fibroblast | 8 studies | 22% ± 6% | |
| epithelial cell | 7 studies | 34% ± 17% | |
| astrocyte | 5 studies | 24% ± 7% | |
| glutamatergic neuron | 5 studies | 30% ± 11% | |
| goblet cell | 5 studies | 25% ± 7% | |
| pancreatic A cell | 4 studies | 43% ± 21% | |
| basal cell | 4 studies | 30% ± 13% | |
| oligodendrocyte | 4 studies | 18% ± 2% | |
| type B pancreatic cell | 3 studies | 47% ± 19% | |
| placental villous trophoblast | 3 studies | 24% ± 10% | |
| pericyte | 3 studies | 20% ± 2% | |
| smooth muscle cell | 3 studies | 19% ± 3% | |
| macrophage | 3 studies | 16% ± 0% | |
| GABAergic neuron | 3 studies | 32% ± 5% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 4% | |
| abnormal cell | 3 studies | 18% ± 2% | |
| intestinal crypt stem cell | 3 studies | 17% ± 2% | |
| interneuron | 3 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2741.81 | 2642 / 2642 | 100% | 36.81 | 705 / 705 |
| esophagus | 100% | 2889.78 | 1445 / 1445 | 100% | 26.75 | 183 / 183 |
| prostate | 100% | 3371.29 | 245 / 245 | 100% | 42.66 | 502 / 502 |
| lung | 100% | 3212.15 | 578 / 578 | 100% | 28.95 | 1154 / 1155 |
| breast | 100% | 3006.66 | 459 / 459 | 100% | 38.61 | 1117 / 1118 |
| uterus | 100% | 3291.18 | 170 / 170 | 100% | 21.75 | 458 / 459 |
| ovary | 100% | 2664.69 | 180 / 180 | 100% | 18.41 | 429 / 430 |
| liver | 100% | 2267.29 | 226 / 226 | 100% | 17.88 | 405 / 406 |
| stomach | 100% | 2751.63 | 359 / 359 | 100% | 25.92 | 285 / 286 |
| kidney | 100% | 2465.10 | 89 / 89 | 99% | 25.65 | 896 / 901 |
| pancreas | 100% | 2149.07 | 328 / 328 | 99% | 23.76 | 177 / 178 |
| thymus | 100% | 3424.41 | 653 / 653 | 99% | 27.10 | 601 / 605 |
| intestine | 100% | 3063.90 | 966 / 966 | 99% | 25.50 | 522 / 527 |
| bladder | 100% | 3175.52 | 21 / 21 | 99% | 23.18 | 499 / 504 |
| adrenal gland | 100% | 3072.13 | 258 / 258 | 98% | 27.52 | 226 / 230 |
| skin | 100% | 2528.57 | 1809 / 1809 | 96% | 24.13 | 453 / 472 |
| adipose | 100% | 2967.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3473.75 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2708.56 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2064.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.65 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.52 | 1 / 1 |
| heart | 99% | 1886.59 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 93% | 1037.49 | 865 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 86% | 12.66 | 69 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 8.17 | 25 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO_0060576 | Biological process | intestinal epithelial cell development |
| GO_0000138 | Cellular component | Golgi trans cisterna |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005801 | Cellular component | cis-Golgi network |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
| GO_0005797 | Cellular component | Golgi medial cisterna |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | YIPF6 |
| Protein name | Protein YIPF6 (YIP1 family member 6) Protein YIPF |
| Synonyms | |
| Description | FUNCTION: May be required for stable YIPF1 and YIPF2 protein expression. . |
| Accessions | ENST00000451537.5 ENST00000462683.6 [Q96EC8-1] Q96EC8 ENST00000374622.3 [Q96EC8-2] B1AV70 |